Insights into the Physiologic Action of the GLP-1 RAs

Program: CMES Ancillary Events
Session: CMES2-Applying the Evidence for GLP-1 Receptor Agonists in Type 2 Diabetes: Practice Perspectives
Clinical
Supported by an educational grant from AstraZeneca
Friday, March 6, 2015: 5:45 AM-8:00 AM
Presentation Start Time: 6:10 AM
Sapphire B (Hilton San Diego Bayfront)
Adrian Vella, MD
Mayo Clinic, Rochester, MN

Disclosure: AV: Consultant, Sanofi, Consultant, Genentech, Inc., Research Funding, Novartis Pharmaceuticals, Research Funding, BioKier.